Human papillomavirus test with cytology triage in organized screening for cervical cancer.

about

Human papillomavirus test with cytology triage in organized screening for cervical cancer.

Item

http://www.wikidata.org/entity/Q38809544

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Human papillomavirus test with ...... screening for cervical cancer.

@en

type

Item

label

Human papillomavirus test with ...... screening for cervical cancer.

@en

prefLabel

Human papillomavirus test with ...... screening for cervical cancer.

@en

P1476

Human papillomavirus test with ...... screening for cervical cancer.

@en

P2093

Ivana Kholová

http://www.w3.org/2001/XMLSchema#string

Johanna Mäenpää

http://www.w3.org/2001/XMLSchema#string

Mika Tirkkonen

http://www.w3.org/2001/XMLSchema#string

Olga Veijalainen

http://www.w3.org/2001/XMLSchema#string

Paula Kujala

http://www.w3.org/2001/XMLSchema#string

Risto Vuento

http://www.w3.org/2001/XMLSchema#string

Saara Kares

http://www.w3.org/2001/XMLSchema#string

Tiina Luukkaala

http://www.w3.org/2001/XMLSchema#string

Veronika Osuala

http://www.w3.org/2001/XMLSchema#string

P2860

American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

Prevalence of high-risk human papilloma virus genotypes and associated risk of cervical precancerous lesions in a large U.S. screening population: data from the ATHENA trial.

The 2001 Bethesda System: terminology for reporting results of cervical cytology.

Human papillomavirus and Papanicolaou tests to screen for cervical cancer.

Comparison of clinical and analytical performance of the Abbott Realtime High Risk HPV test to the performance of hybrid capture 2 in population-based cervical cancer screening.

Comparison of clinical performance of Abbott RealTime High Risk HPV test with that of hybrid capture 2 assay in a screening setting.

Rate of cervical cancer, severe intraepithelial neoplasia, and adenocarcinoma in situ in primary HPV DNA screening with cytology triage: randomised study within organised screening programme

Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening?

P304

1220-1227

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/AOGS.13013

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-09-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27591407

http://www.w3.org/2001/XMLSchema#string